Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies

Tumor genetic testing is standard of care for patients with advanced lung adenocarcinoma but the fraction of patients who derive clinical benefit remains undefined. Here, we report the experience of 860 patients with metastatic lung adenocarcinoma analyzed prospectively for mutations in >300 canc...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Discov
Huvudupphovsmän: Jordan, Emmet J., Kim, Hyunjae R., Arcila, Maria E., Barron, David, Chakravarty, Debyani, Gao, JianJiong, Chang, Matthew T., Ni, Andy, Kundra, Ritika, Jonsson, Philip, Jayakumaran, Gowtham, Gao, Sizhi Paul, Johnsen, Hannah C., Hanrahan, Aphrothiti J., Zehir, Ahmet, Rekhtman, Natasha, Ginsberg, Michelle S., Li, Bob T., Yu, Helena A., Paik, Paul K., Drilon, Alexander, Hellmann, Matthew D., Reales, Dalicia N., Benayed, Ryma, Rusch, Valerie W., Kris, Mark G., Chaft, Jamie E., Baselga, Jose, Taylor, Barry S., Schultz, Nikolaus, Rudin, Charles M., Hyman, David M., Berger, Michael F., Solit, David B., Ladanyi, Marc, Riely, Gregory J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482929/
https://ncbi.nlm.nih.gov/pubmed/28336552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-16-1337
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk